PIK3CA and non-small cell lung carcinoma: 38630555 38630555 Grazini U, Markovets A, Ireland L et al (2024) Overcoming Osimertinib Resistance with AKT Inhibition in EGFRm-Driven Non-Small Cell Lung Cancer with PIK3CA/PTEN Alterations.